We are live on ! Find out more
SHI

SV Health Investors Portfolio holdings

AUM $32.3M
1-Year Est. Return 20.15%
This Fund
S&P 500
This Quarter Est. Return
-4.68%
1 Year Est. Return
-20.15%
3 Year Est. Return
+97.4%
5 Year Est. Return
+328.26%
10 Year Est. Return
–
AUM
$200M
AUM Growth
+$22.4M
Cap. Flow
+$38.2M
Cap. Flow %
19.08%
Top 10 Hldgs %
100%
Holding
3
New
1
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
OCUL icon
Ocular Therapeutix
OCUL
+$38.2M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ISEE
1
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$129M 64.27%
3,308,695
– –
OCUL icon
2
Ocular Therapeutix
OCUL
$2.38B
$38.7M 19.31%
+2,585,607
New +$38.2M
ASXC
3
DELISTED
Asensus Surgical, Inc.
ASXC
$32.9M 16.42%
580,515
– –

Similar funds

SAM
Serengeti Asset Management New York $31.8M AUM 23.16% 1-Year Est. Return
FCOMV
Foresite Capital Opportunity Management V Larkspur, California $33.3M AUM 47.04% 1-Year Est. Return
LUGPSI
Lightspeed Ultimate General Partner Select III Menlo Park, California $31M AUM 76.89% 1-Year Est. Return
VCA
VIEX Capital Advisors Sunny Isles Beach, Florida $30.9M AUM 55.48% 1-Year Est. Return
PGM
Parian Global Management Pound Ridge, New York $30.8M AUM 51.25% 1-Year Est. Return
ACM
Afton Capital Management Charlotte, North Carolina $30.6M AUM 56.8% 1-Year Est. Return
KCM
Kingstown Capital Management New York $30.4M AUM 3.71% 1-Year Est. Return
KXA
KPCB XV Associates Menlo Park, California $35.8M AUM 57.59% 1-Year Est. Return

SV Health Investors's Q3 2014 Portfolio in Review

As of Q3 2014, SV Health Investors held 3 positions worth $200M, up 13% from $178M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

SV Health Investors deployed $38.2M of net new capital in Q3 2014, opening 1 new position. Its largest new stake was Ocular Therapeutix: 2,585,607 shares worth $38.7M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • SV Health Investors's largest Q3 2014 buy was Ocular Therapeutix: 2,585,607 shares worth $38.7M.
  • SV Health Investors's ten largest holdings make up 100% of its $200M portfolio in Q3 2014.
  • SV Health Investors opened 1 new position and closed 0 in Q3 2014.
  • SV Health Investors's portfolio value rose 13% quarter-over-quarter to $200M.

Based on SV Health Investors's 13F filing for Q3 2014, filed 14 Nov 2014.